Pfizer chief, Gates use Africans in PR stunt to push even more vaccines
By TONY MOBILIFONITIS
PFIZER CEO and chairman Albert Bourla and Bill Gates (surprise, surprise) are again pushing vaccines on pregnant women in African and other low-income nations under the guise of running a so-called Health Accord.
The launch of the Accord at the World Economic Forum in Davos also doubled as a PR stunt with the Pfizer chief schmoozing up to the presidents of Rwanda and Malawi. Resistance to vaccination campaigns is strong in Africa. In 2014 Kenya’s Catholic Doctor’s Association accused the government of employing population control by stealth, after they discovered a tetanus vaccine targeted exclusively at women of childbearing age was laced with a birth control hormone called beta human chorionic gonadotropin (HCG).
The HCG was found in all six vaccine samples sent to the University of Nairobi medical laboratory and another in South Africa. The Catholic doctors discovered the Kenya Ministry of Health had not tested the vaccine, but merely trusted it because it originated from WHO (World Health Organization), supposedly a credible organisation in matters of health.
HCG was developed by the WHO in 1992 and employed five injections. It was used in Mexico in 1993 and Nicaragua and the Philippines in 1994 and was reported to have caused miscarriages three years later. The doctors said WHO tried to bring the same anti-fertility program into Kenya in the 1990s but were stopped.
Now Gates, in league with Pfizer, is pushing two new vaccines (group B pneumococcal and “RC”) for mothers in 45 low and middle-income nations representing 1.2 billion people. Gates and Bourla say it’s all about promoting “health equity”.
Pfizer will supply vaccines and all of its other medical products allegedly at non-profit rates, which won’t be difficult to do, given the low value currencies of these nations and subsidies from the IMF, World Bank, WHO and other agencies pushing the global pharmaceutical agenda.
And given that these nations already have access to much cheaper generic pharmaceutical products it’s likely the Pfizer scheme has the ulterior motive of pushing those products out or at least replacing them. Kenya is also producing it
Politicians and bureaucrats in these countries will no doubt reap some “special incentives” for signing up to the Pfizer-Gates scheme as well. It is also highly likely that all sorts of regulatory changes in their national health systems, if not direct control by the WHO, will run in tandem with this scheme.
Gates’ and Bourla’s appearance on the WEF stage with the Rwandan and Malawi presidents was a not so subtle display of virtue signaling. Also on the platform was Angela Kwang, group president of Pfizer Biopharmaceutical Group.
The combined Gross Domestic Product (GDP) of Malawi and Rwanda is about US$22.29 billion. Pfizer’s COVID vaccines sales for 2021 totaled US$37 billion and are projected to reach $54 billion this year. One doesn’t have to be an economic wizard to see the attraction of poor African states to Pfizer-Gates’ “special deal” on discounted vaccines and other medicines.